Company / Current Assets
Neurogene Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$271.8M
FY2025
5-year range
$77.2M / $315.9M
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $144M to $272M over the past 6 years.
Based on SEC 10-K filings.
$272M in FY2025.
Improved from $144M to $272M over the past 6 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets decreased 14.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $271.8M | -14.0% |
| FY2024 | $315.9M | +120.0% |
| FY2019 | $143.6M | +86.1% |
| FY2018 | $77.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026